Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3134]

Therapeutic strategies based on evolutionary principles may improve patient outcomes

Therapeutic strategies based on evolutionary principles may improve patient outcomes

FDA approves daratumumab for multiple myeloma patients ineligible for autologous stem cell transplant

FDA approves daratumumab for multiple myeloma patients ineligible for autologous stem cell transplant

Natural antioxidant helps improve immune-based therapies by modulating T-cells

Natural antioxidant helps improve immune-based therapies by modulating T-cells

High doses of 60 plus-year-old chemotherapy drug found to spur immune system attack on lymphoma

High doses of 60 plus-year-old chemotherapy drug found to spur immune system attack on lymphoma

Childhood leukaemia cannot hide from the immune system

Childhood leukaemia cannot hide from the immune system

The evolution of CML management: why is patient engagement more important than ever?

The evolution of CML management: why is patient engagement more important than ever?

Research discovery leads to new clinical trial for myelofibrosis patients

Research discovery leads to new clinical trial for myelofibrosis patients

Human-on-a-chip model tests cancer drug efficacy and toxicity for therapeutic index

Human-on-a-chip model tests cancer drug efficacy and toxicity for therapeutic index

$EHA 2019: Acalabrutinib shows remarkable benefit in relapsed or refractory chronic lymphocytic leukaemia$

EHA 2019: Acalabrutinib shows remarkable benefit in relapsed or refractory chronic lymphocytic leukaemia

$EHA 2019: Venetoclax with bortezomib and dexamethasone shows good response but higher risk of treatment related death in relapsed / refractory multiple myleoma$

EHA 2019: Venetoclax with bortezomib and dexamethasone shows good response but higher risk of treatment related...

More from ecancer